Research may lead to improved vaccines for respiratory infections

Jan 18, 2011

A collaborative project between researchers at the Trudeau Institute and their colleagues at St. Jude Children's Research Hospital in Memphis, Tenn., offers new insights that may lead to an improved strategy to protect against the influenza virus and other viruses that infect the respiratory tract.

The study examines the migration of to the mucosal tissues of the nose in response to a viral infection.

"As a result of this study, we learned that cells arrive early during the infection and persist at the site for months afterwards, providing a first line of defense against a second infection with the virus," said David L. Woodland, Ph.D., president and director of the Trudeau Institute and one of the study's authors.

"These cells are 'soldiers' that guard nasal passages and combat viruses at their site of entry. In the future, a single application of by or drops may be all that is needed for long-term protection against some serious respiratory virus infections," said Dr. Julia L. Hurwitz, Ph.D., Full Member of the Department of Infectious Diseases at St. Jude Children's Research Hospital.

This new information, reported in the current issue of the scientific journal Virology, has major implications for future vaccine research and could lead to the development of vaccines designed to promote immunity to respiratory infections.

"The migration patterns and characteristics of these cells are of particular interest, since they are the very cells one would like to elicit with a vaccine," said Woodland.

Scientists are working toward the ultimate goal of developing a universal , capable of protecting against all strains of flu, including seasonal and those that develop into pandemics. Vaccines for the parainfluenza viruses and respiratory syncytial virus are also being sought. The Trudeau and St. Jude research groups are optimistic that this new information is an important contribution to that end.

Explore further: Growing a blood vessel in a week

add to favorites email to friend print save as pdf

Related Stories

Directing immune traffic -- signposts to the lung

May 10, 2010

Inducing cellular immunity as a means to protect against influenza virus is the focus of several laboratories at the Trudeau Institute. Researchers here have recently identified two important signaling components ...

Unusual flu vaccine is developed

Jun 14, 2006

U.S. scientists have used reverse genetics to develop an influenza virus with two key proteins on its surface derived from the H5N1 avian virus strain.

Recommended for you

Growing a blood vessel in a week

4 hours ago

The technology for creating new tissues from stem cells has taken a giant leap forward. Three tablespoons of blood are all that is needed to grow a brand new blood vessel in just seven days. This is shown ...

Testing time for stem cells

7 hours ago

DefiniGEN is one of the first commercial opportunities to arise from Cambridge's expertise in stem cell research. Here, we look at some of the fundamental research that enables it to supply liver and pancreatic ...

Team finds key signaling pathway in cause of preeclampsia

Oct 23, 2014

A team of researchers led by a Wayne State University School of Medicine associate professor of obstetrics and gynecology has published findings that provide novel insight into the cause of preeclampsia, the leading cause ...

Rapid test to diagnose severe sepsis

Oct 23, 2014

A new test, developed by University of British Columbia researchers, could help physicians predict within an hour if a patient will develop severe sepsis so they can begin treatment immediately.

User comments : 0